NEOJAPAN Inc.
NEOJAPAN Inc. (NEOJF) Financial Performance & Income Statement Overview
Analyze NEOJAPAN Inc. (NEOJF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
NEOJAPAN Inc. (NEOJF) Income Statement & Financial Overview
Review NEOJAPAN Inc. NEOJF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.98B | $1.92B | $1.68B | $1.69B |
| Cost of Revenue | $886.09M | $844.97M | $748.62M | $751.77M |
| Gross Profit | $1.09B | $1.07B | $929.96M | $935.84M |
| Gross Profit Ratio | $0.55 | $0.56 | $0.55 | $0.55 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $24.28M |
| SG&A Expenses | $518.94M | $544.008M | $506.31M | $475.16M |
| Operating Expenses | $518.94M | $544.008M | $518.44M | $499.44M |
| Total Costs & Expenses | $1.41B | $1.39B | $1.27B | $1.25B |
| Interest Income | $0.00 | $0.00 | $17.44M | $17.40M |
| Interest Expense | $0.00 | $0.00 | $12000.00 | $6000.00 |
| Depreciation & Amortization | $98.93M | $59.40M | $67.81M | $59.81M |
| EBITDA | $692.66M | $590.31M | $495.43M | $468.96M |
| EBITDA Ratio | $0.35 | $0.31 | $0.30 | $0.28 |
| Operating Income | $572.36M | $530.90M | $411.52M | $436.40M |
| Operating Income Ratio | $0.29 | $0.28 | $0.25 | $0.26 |
| Other Income/Expenses (Net) | $21.36M | $29.47M | $16.09M | $32.56M |
| Income Before Tax | $593.72M | $560.37M | $427.61M | $468.95M |
| Income Before Tax Ratio | $0.30 | $0.29 | $0.25 | $0.28 |
| Income Tax Expense | $163.36M | $179.00M | $140.84M | $153.34M |
| Net Income | $430.37M | $381.37M | $286.76M | $315.61M |
| Net Income Ratio | $0.22 | $0.20 | $0.17 | $0.19 |
| EPS | $30.70 | $27.20 | $20.50 | $21.95 |
| Diluted EPS | $30.70 | $27.20 | $20.49 | $21.91 |
| Weighted Avg Shares Outstanding | $14.02M | $14.02M | $13.99M | $14.38M |
| Weighted Avg Shares Outstanding (Diluted) | $14.02M | $14.02M | $14.00M | $14.41M |
Over the past four quarters, NEOJAPAN Inc. demonstrated steady revenue growth, increasing from $1.69B in Q1 2024 to $1.98B in Q4 2024. Operating income reached $572.36M in Q4 2024, maintaining a consistent 29% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $692.66M, reflecting operational efficiency. Net income rose to $430.37M, with EPS at $30.70. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan